Perceptions on basilar artery occlusion management in China versus other countries: Analysis of the after the BEST of BASICS (ABBA) survey

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00159816%3A_____%2F22%3A00077413" target="_blank" >RIV/00159816:_____/22:00077413 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/65269705:_____/22:00077413 RIV/00216224:14110/22:00128744

Výsledek na webu

<a href="https://www.sciencedirect.com/science/article/pii/S1052305722004980?via%3Dihub" target="_blank" >https://www.sciencedirect.com/science/article/pii/S1052305722004980?via%3Dihub</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2022.106804" target="_blank" >10.1016/j.jstrokecerebrovasdis.2022.106804</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Perceptions on basilar artery occlusion management in China versus other countries: Analysis of the after the BEST of BASICS (ABBA) survey

Popis výsledku v původním jazyce

Introduction: Uncertainty remains on the optimal management of basilar artery occlusion (BAO). Two large randomized controlled trials (RCTs) in 2019 and 2021 demonstrated neutral results with respect to the use of endovascular therapy (EVT) for BAO. This study aimed to understand regional variation in physicians&apos; percep-tions towards the treatment of BAO as stratified by physician respondents from China versus outside China, prior to the publication of studies demonstrating a benefit of EVT for BAO. Methods: An international online survey was conducted of stroke neurologists and neurointerventionalists from January to March 2022. Sur-vey questions evaluated physician opinions toward the use of EVT in BAO, as well as the clinical and imaging features underlying treatment decisions. Respondents were dichotomized as either from China or from other countries and differences between groups were analyzed. Results: There were 1245 physician respondents across 73 countries of which 295 (23.7%) were from China. Compared to respond-ents from the rest of the world, respondents from China were more likely to be interventionalists (71.5% vs 35.0%; p &lt; 0.0001). Overall, more than 95% of respond-ents believed that EVT was superior to medical therapy under certain circumstan-ces. Chinese respondents were more likely to believe that further RCTs were necessary than respondents from other countries (93.6% vs 76.2%; p &lt; 0.0001). Chi-nese respondents were more likely to use advanced imaging in later time windows and use a premorbid mRS threshold of &lt;2 for BAO selection to EVT. Conclusion: Most stroke physicians believe EVT is beneficial in selected patients with BAO. Clinical and imaging modality differences were observed in the selection criteria used for EVT. There was greater inclination to enroll all trial eligible patients in a BAO RCT by respondents from China as compared to other parts of the world.

Název v anglickém jazyce

Perceptions on basilar artery occlusion management in China versus other countries: Analysis of the after the BEST of BASICS (ABBA) survey

Popis výsledku anglicky

Introduction: Uncertainty remains on the optimal management of basilar artery occlusion (BAO). Two large randomized controlled trials (RCTs) in 2019 and 2021 demonstrated neutral results with respect to the use of endovascular therapy (EVT) for BAO. This study aimed to understand regional variation in physicians&apos; percep-tions towards the treatment of BAO as stratified by physician respondents from China versus outside China, prior to the publication of studies demonstrating a benefit of EVT for BAO. Methods: An international online survey was conducted of stroke neurologists and neurointerventionalists from January to March 2022. Sur-vey questions evaluated physician opinions toward the use of EVT in BAO, as well as the clinical and imaging features underlying treatment decisions. Respondents were dichotomized as either from China or from other countries and differences between groups were analyzed. Results: There were 1245 physician respondents across 73 countries of which 295 (23.7%) were from China. Compared to respond-ents from the rest of the world, respondents from China were more likely to be interventionalists (71.5% vs 35.0%; p &lt; 0.0001). Overall, more than 95% of respond-ents believed that EVT was superior to medical therapy under certain circumstan-ces. Chinese respondents were more likely to believe that further RCTs were necessary than respondents from other countries (93.6% vs 76.2%; p &lt; 0.0001). Chi-nese respondents were more likely to use advanced imaging in later time windows and use a premorbid mRS threshold of &lt;2 for BAO selection to EVT. Conclusion: Most stroke physicians believe EVT is beneficial in selected patients with BAO. Clinical and imaging modality differences were observed in the selection criteria used for EVT. There was greater inclination to enroll all trial eligible patients in a BAO RCT by respondents from China as compared to other parts of the world.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30103 - Neurosciences (including psychophysiology)

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2022

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Journal of Stroke &amp; Cerebrovascular Diseases

ISSN

1052-3057

e-ISSN

1532-8511

Svazek periodika

31

Číslo periodika v rámci svazku

11

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

10

Strana od-do

106804

Kód UT WoS článku

000933363500001

EID výsledku v databázi Scopus

2-s2.0-85139336022